Journal of Perioperative Echocardiography

Register      Login

VOLUME 7 , ISSUE 2 ( July-December, 2019 ) > List of Articles

REVIEW ARTICLE

Role of Echocardiography in COVID-19 Patients

Citation Information : Role of Echocardiography in COVID-19 Patients. J Perioper Echocardiogr 2019; 7 (2):33-35.

DOI: 10.5005/jp-journals-10034-1101

License: CC BY-NC 4.0

Published Online: 01-12-2019

Copyright Statement:  Copyright © 2019; The Author(s).


Abstract

Coronavirus disease-2019 (COVID-19) pandemic has created new challenges for the healthcare systems all over the world. The incidence of myocardial injury ranges between 7 and 20% in hospitalized COVID-19 patients.1 The term myocardial injury applies to any patient in whom at least one cardiac troponin (cTn) concentration is above the 99th percentile upper reference limit. The death rate in COVID-19 patients with cardiac disease as comorbidity has around 10%. Myocardial injuries might be related to the fulminant cytokine release and systemic inflammation seen in severe COVID-19 cases.2 The role of echocardiographer is crucial as echocardiography is an easily available non-invasive bedside modality to assess for cardiac involvement as well as cardiorespiratory interactions in patients with COVID-19. However, sonographers are also at risk of being infected during the performance of echocardiogram, due to the prolonged and close contact with COVID-19 patients. Hence, appropriate protective measures are necessary to enable the best medical care for patients while also maintaining the health of the sonographer, especially in the setting of a shortage of expert staff (sickness or quarantine after duty) and to prevent transmission to other staff and patients. This article presents a clinical case series of a range of cardiac involvement in COVID-19 and offers guidance on indications of echocardiogram and safe practices for performing safe and effective echocardiography during the COVID-19 pandemic, with particular focus on echocardiography of suspected or confirmed COVID-19 cases. Echocardiography during COVID-19 is a clinically useful tool. Due to concerns about transmission of disease during performing an echo, the procedure should be streamlined, performed by skilled practitioners who are not at high-risk for COVID-19 severe disease, and with a focus on obtaining the best possible transthoracic images.


HTML PDF Share
  1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497–506. DOI: 10.1016/S0140-6736(20)30183-5.
  2. Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395(10229):1033–1034. DOI: 10.1016/S0140-6736(20)30628-0.
  3. Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol 2020;5(7):802–810. DOI: 10.1001/jamacardio.2020.0950.
  4. Neskovic AN, Skinner H, Price S. Focus cardiac ultrasound core curriculum and core syllabus of the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging 2018;19(5):475–481. DOI: 10.1093/ehjci/jey006.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.